Epidemiology and characteristics of validated mixed phenotype acute leukaemia—A comprehensive nationwide Danish cohort study

Lisa‐Maj Christensen(Aalborg University Hospital), Marianne Tang Severinsen(Aalborg University Hospital), Karen Dybkær(Aalborg University Hospital), Daniel Tuyet Kristensen(Aalborg University Hospital), Tarec Christoffer El‐Galaly(Aalborg University Hospital), Dennis Lund Hansen(Odense University Hospital), Hans Beier Ommen(Centre de Recherche Jean Pierre Aubert), Marianne Schmidt Ettrup(Aalborg University Hospital), Anne Louise Tølbøll Sørensen(University of Copenhagen), Rasmus Froberg Brøndum(Aarhus University), Jonas Faartoft Jensen, Kirsten Grønbæk(University of Copenhagen)
British Journal of Haematology
October 28, 2025
10.1111/bjh.70235
Cited by 1

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
Real-Time Quantitative Polymerase Chain Reaction Detection of Minimal Residual Disease by Standardized <i>WT1</i> Assay to Enhance Risk Stratification in Acute Myeloid Leukemia: A European LeukemiaNet Study
|Journal of Clinical Oncology|2009|434
Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study
|Blood|2012|396
Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
|Blood|2009|390
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study
|Leukemia|2012|362